The 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy

Conference Reports for NATAP


The 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 23-24, 2010

	Meeting Report - 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy - by Jennifer Kiser PharmD - (07/05/10) Regulatory Requirements for Early Clinical Testing of Novel HCV Antiviral Drugs: FDA Perspective, Jeff Murray, M.D., M.P.H. FDA, Division of Antiviral Products - (06/25/10) A European Perspective: EMA and his critical standpoint, Prof. Jean-Michel Pawlotsky, MD, PhD - (06/23/10)